News

Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Update

MONTREAL, July 07, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the…

2 years ago

Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)

OCA 25 mg met the agreed primary endpoint of improvement in liver fibrosis without worsening of NASH at 18 months…

2 years ago

Clearside Biomedical Suprachoroidal Delivery Technology to be Featured at Upcoming ASRS and OIS Medical Meetings

- Multiple Podium and Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® - ALPHARETTA, Ga., July 07,…

2 years ago

Arcoma Precision i5 approved for sales in Singapore

2022-07-07 PRESSRELEASE Arcoma Precision i5 approved for sales in Singapore Arcoma has many installations in Singapore and we are, together…

2 years ago

Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022

Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022 - Key highlights include…

2 years ago

Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study

VANCOUVER, British Columbia, July 07, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…

2 years ago

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

Debora Barton Debora BartonWALTHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company…

2 years ago

XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

2 years ago

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

SEATTLE and CAMBRIDGE, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company…

2 years ago

BioAdaptives, Inc. Introduces PrimiSleep™, An Advanced Sleep-Aid Designed to Harmonize with the Body’s Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No “Hangover”

PrimiSleep™ Enters Rapidly Growing Global Sleep Aid Market With State-of-the-Art Supplement LAS VEGAS, NV, July 07, 2022 (GLOBE NEWSWIRE) --…

2 years ago